← Leaderboards
Natalia Nieto
Mount Sinai School Of Medicine Of Nyu
$11,228,892
Attributed
$11,228,892
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $915.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,228,892 · 8
VA$0 · 1
By mechanism
R01$8,633,614 · 5
U01$2,031,183 · 1
R56$544,095 · 1
R13$20,000 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Scott Laurence Friedman$20,818,456
- Frederick J Suchy$8,245,458
- Meena B Bansal$2,236,167
- Francesco B Ramirez$19,751,082
Others in their field
Top investigators on “Hepatocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Mark A Kay · Stanford University$31,244,013
- Charles M. Rice · Rockefeller University$27,314,965
- Stephen Lev Hoffman · Sanaria, Inc.$26,407,941
- Stefan H.i. Kappe · Seattle Children'S Hospital$25,211,763
- Michael H Nathanson · Yale University$22,903,080
Research focus
HepatocytePreventLiverFeedingProductionAlcoholic Liver DiseasesAffectMediatingKupffer CellsResponseHepaticMolecularInjuryDesignAlcoholsIn VivoCytokineMacrophageCellsEthanolChronicInflammationLinkEvent
Grant awards (39)
Protective role of OPN-High macrophages in NASH$516,060
R01 · FY2025 · DK · contact PI
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease$0
I01 · FY2025 · VA · contact PI
Protective role of OPN-High macrophages in NASH$495,418
R01 · FY2024 · DK · contact PI
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease$0
I01 · FY2024 · VA · contact PI
Protective role of OPN-High macrophages in NASH$533,838
R01 · FY2023 · DK · contact PI
22nd Liver Sinusoid Meeting$20,000
R13 · FY2023 · AA · contact PI
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease$0
I01 · FY2023 · VA · contact PI
High-mobility group box-1 and alcoholic liver disease$359,775
R01 · FY2022 · AA · contact PI
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease$0
I01 · FY2022 · VA · contact PI
High-mobility group box-1 and alcoholic liver disease$359,775
R01 · FY2021 · AA · contact PI
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease$0
I01 · FY2021 · VA · contact PI
Pathogenic role of hepatocyte-derived high-mobility group box-1 isoforms as potential therapeutic targets to prevent and/or resolve liver fibrosis$476,043
R01 · FY2020 · DK · contact PI
High-mobility group box-1 and alcoholic liver disease$359,775
R01 · FY2020 · AA · contact PI
Pathogenic role of hepatocyte-derived high-mobility group box-1 isoforms as potential therapeutic targets to prevent and/or resolve liver fibrosis$504,825
R01 · FY2019 · DK · contact PI
High-mobility group box-1 and alcoholic liver disease$359,775
R01 · FY2019 · AA · contact PI
Pathogenic role of hepatocyte-derived high-mobility group box-1 isoforms as potential therapeutic targets to prevent and/or resolve liver fibrosis$518,391
R01 · FY2018 · DK · contact PI
High-mobility group box-1 and alcoholic liver disease$356,001
R01 · FY2018 · AA · contact PI
Pathogenic role of hepatocyte-derived high-mobility group box-1 isoforms as potential therapeutic targets to prevent and/or resolve liver fibrosis$516,495
R01 · FY2017 · DK · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$95,930
U01 · FY2017 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$383,520
U01 · FY2016 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$372,013
U01 · FY2015 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$222,174
U01 · FY2014 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$172,422
U01 · FY2014 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$378,324
U01 · FY2013 · AA · contact PI
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis$406,800
U01 · FY2012 · AA · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$362,911
R01 · FY2012 · AA · contact PI
Osteopontin and the fibrogenic response to liver injury$120,345
R56 · FY2012 · DK · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$25,000
R01 · FY2012 · AA · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$362,911
R01 · FY2011 · AA · contact PI
Osteopontin and the fibrogenic response to liver injury$423,750
R56 · FY2010 · DK · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$377,561
R01 · FY2010 · AA · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$356,355
R01 · FY2009 · AA · contact PI
Communication between Kupffer cells and stellate cells$242,555
R01 · FY2009 · DK · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$187,810
R01 · FY2009 · AA · contact PI
ASS, NOS2, AND ALCOHOLIC LIVER DISEASE$356,355
R01 · FY2008 · AA · contact PI
Communication between Kupffer cells and stellate cells$242,555
R01 · FY2008 · DK · contact PI
Communication between Kupffer cells and stellate cells$247,504
R01 · FY2007 · DK · contact PI
Communication between Kupffer cells and stellate cells$254,896
R01 · FY2006 · DK · contact PI
Communication between Kupffer cells and stellate cells$261,030
R01 · FY2005 · DK